Definitive Contract 75N93022C00036
Award Date
9/1/22
Potential Completion Date
8/31/27
Potential Value
$33M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Seattle Children's Hospital
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Seattle, WA 98105, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Seattle Children's Hospital, doing business as Seattle Children's Research Institute, for the Structural Genomics Centers for Infectious Diseases program. The contract has a potential value of $25,252,157.23 and runs from September 1, 2017 through August 31, 2022. It is a cost plus fixed fee definitive contract with no...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Washington (UW). The contract, valued at $7,822,728.37, is for biomedical research services under the Population Genetics Analysis Program. The contract is a definitive, cost-no-fee type and does not have a set-aside designation. UW is a leading public research university that has extensive experience in supporting federal agencies through prime contract and grant...
This $5,635,564.60 cost-reimbursable definitive contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance), a non-profit medical research organization. The contract supports targeted clinical research to address select viral infections. There was no set-aside designation. Under the contract, Fred Hutchinson Cancer Center is...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to Seattle Children's Hospital to conduct research on tuberculosis. The $87,790,431 contract, which has no set-aside designation, is for the "Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)". The prime contractor is Seattle Children's Hospital, doing business as Seattle Children's Research Institute, a...
This is a $42,154,564 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Seattle Children's Hospital, doing business as Seattle Children's Research Institute. The contract is for the Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB) and does not have a set-aside designation. The contract involves examining the basic induction of innate and adaptive immunity from vaccination, including studies on nontuberculous...
This federal contract award, valued at $32,396.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to the University of Washington School of Medicine, doing business as the University of Washington Department of Laboratory Medicine. The contract, which is a firm-fixed price purchase order, is for Immunoplex Sequencing services. The award was made on a sole-source basis, as NIAID determined that the University of...
This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the University of Washington (UW) to ensure standardization and comparability of functional genomics services and assays conducted for the NIAID Simian Vaccine Evaluation Units and Division of AIDS (DAIDS)-supported preclinical nonhuman primate studies. The contract has a ceiling value of $17,317,765.02 and a period...
This is a $5,491,304.00 cost-reimbursement contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Washington (UW) to conduct large-scale T-cell epitope discovery research. The contract has a completion date of September 29, 2025 and is not a set-aside award. As the prime contractor, UW will perform the research work. UW has a subcontract with Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), a foreign government hospital, to...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS), to the Seattle Biomedical Research Institute (doing business as the Center for Infectious Disease Research), a non-profit organization. The $13,104 firm-fixed-price purchase order is for IT access and collaboration services. The award does not have a set-aside designation. The contract supports NIAID's mission of...
This is a federal contract award from the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to Northwestern University. The award is a 5-year definitive contract with a potential value of $25,631,560.21 to support the "Structural Genomics Centers for Infectious Diseases" program. This contract does not have a set-aside designation. As the prime contractor, Northwestern University will provide research,...